Radiation dose ≥54 Gy and CA 19–9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation

Table 1 Patient and treatment characteristics stratified by radiotherapy dose < or ≥ 54 Gy

		All	<54 Gy	≥54 Gy	p value
Number of patients		46	21	25
Age at start of CRT, years (Median)		61	63	59	0.089
BMI kg/m2 (Median)		26.5	26.8	25.9	0.757
Exploratory laparotomy	No	37	16	21
	Yes	9	5	4	0.506
T classification*	T3	5	2	3
	T4	41	19	22	0.788
N classification	N0	24	12	12
	N1	22	9	13	0.536
Histology	Adenocarcinoma	43	21	22
	Other	3	0	3	0.101
IMRT	No	16	10	6
	Yes	30	11	19	0.094

*T4 classification includes patients unresectable at exploratory laparotomy.
(BMI = body mass index; CRT = chemoradiation; IMRT = intensity modulated radiotherapy).

ISSN: 1748-717X